Top View
- Recombinant BRD3 (24-144) Protein Catalog No: 31379, 31779 Quantity: 100, 1000 Μg Lot No: 32717003 Concentration: 1.8 Μg/Μl Expressed In: E
- Distinct Roles of Brd2 and Brd4 in Potentiating the Transcriptional Program for Th17 Cell Differentiation
- Relevance of BET Family Proteins in SARS-Cov-2 Infection
- BRD4 Hyperphosphorylation Associated PNAS PLUS with Cellular Transformation in NUT Midline Carcinoma
- Current Understanding of the Role of the Brd4 Protein in the Papillomavirus Lifecycle
- BET Proteins in Abnormal Metabolism, Inflammation, and the Breast Cancer Microenvironment
- Mir-3140Suppresses Tumor Cell Growth by Targeting BRD4 Via Its
- BRD4-NUT Fusion Oncogene: a Novel Mechanism in Aggressive Carcinoma1
- BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance
- BRD4 PROTAC Degrader ARV-825 Inhibits T
- BRD2 Regulation of Sigma-2 Receptor Expression Upon Cytosolic Cholesterol Deprivation
- Bromodomain Protein Brd3 Associates with Acetylated GATA1 to Promote
- PLX51107, a Promising Novel Bromodomain and Extra-Terminal Inhibitor in Chronic Lymphoid Leukemia Treatment
- Inhibition of BRD4 Suppresses the Malignancy of Breast Cancer Cells Via Regulation of Snail
- The Therapeutic Effect of the BRD4-Degrading PROTAC A1874
- YY1 Cistrome Analysis Uncovers an Essential Requirement of the YY1:BRD4-PFKP
- Discovery and Characterization of Bromodomain 2–Specific Inhibitors of BRDT
- BRD4 Bromodomain 1 TR-FRET Assay Kit
- BRD3 Full-Length (His) (Bromodomain Containing Protein 3 (RING3L))
- BRD3-2 (GST) (Bromodomain Containing Protein 3 (RING3L), Bromodomain 2)
- Targetable BET Proteins- and E2F1-Dependent Transcriptional Program Maintains the Malignancy of Glioblastoma
- An Epigenetic Screening Determines BET Proteins As Targets to Suppress Self-Renewal and Tumorigenicity in Canine Mammary Cancer Cells Pedro L
- Compensatory Induction of MYC Expression by Sustained CDK9 Inhibition Via A
- JAK2 Is Dispensable for Maintenance of JAK2 Mutant B-Cell Acute Lymphoblastic Leukemias
- GSK046: a BD2 Selective Inhibitor of BRD2, BDR3, BRD4, BRDT Family
- BRD4 Interacts with GATA4 to Govern Mitochondrial Homeostasis in Adult Cardiomyocytes
- The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins
- Structure of the Human Clamp Loader Bound to the Sliding Clamp: a Further Twist on AAA+ Mechanism
- Gata1s Induces Hyperproliferation of Eosinophil Precursors in Down Syndrome Transient Leukemia
- Bromodomain Protein Brd4 Plays a Key Role in Merkel Cell Polyomavirus DNA Replication
- Product Datasheet RFC5 Antibody NB100-235
- Replication Collision Events and DNA Damage ✉ Fred C
- Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents Against MYC
- Systematic Bromodomain Protein Screens Identify Homologous Recombination and R-Loop Suppression Pathways Involved in Genome Integrity
- Leveraging DNA Damage Response Pathways to Enhance the Precision of CRISPR-Mediated Genome Editing
- Hematopoietic Stem Cells Made Better by Inhibition Ludovica Marando1,2,3 and Brian J
- BET Bromodomain Inhibitors Synergize with ATR Inhibitors to Induce DNA Damage, Apoptosis, Senescence-Associated Secretory Pathwa
- Table S9 SFARI and OMIM Genes V2.Xlsx
- BRD4 Regulates EZH2 Transcription Through Upregulation of C-MYC
- A Dissertation Entitled Bromodomain Containing Proteins in Melanocyte
- Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth
- Antileukemic Efficacy of BET Inhibitor in a Preclinical Mouse Model of MLL-AF4 + Infant ALL
- Ectopic Protein Interactions Within BRD4–Chromatin Complexes Drive Oncogenic Megadomain Formation in NUT Midline Carcinoma
- Discovery of RSV-Induced BRD4 Protein Interactions Using Native Immunoprecipitation and Parallel Accumulation—Serial Fragmentation (PASEF) Mass Spectrometry